Latest News and Press Releases

Omsætning og EBITDA på linje med forventningerne til 2020. Likvider ved årets udgang var bedre end forventet. KØBENHAVN, Danmark, 28. januar 2021 – Bavarian Nordic A/S (OMX: BAVA) rapporterede i dag...

Revenue and EBITDA in line with guidance for 2020. Year-end cash position better than guided for 2020 COPENHAGEN, Denmark, January 28, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today...

Opdaterede vedtægter for Bavarian Nordic A/S. Vedhæftet fil Bavarian Nordic - Vedtægter ...

Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic - Articles of Association ...

KØBENHAVN, Danmark, 5. januar 2021 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået kontrakter med regeringerne i tre europæiske lande omkring levering af koppevaccinen...

COPENHAGEN, Denmark, January 5, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has entered into contracts with three European governments for the supply of...

Forsøget viste tegn på klinisk aktivitet, men nåede ikke det primære endemålTo igangværende fase 1-forsøg undersøger intravenøs behandling af chordoma-patienter med to forskellige MVA-baserede...

Study showed signs of clinical activity, but failed to meet the primary endpoint of the Phase 2 studyTwo ongoing phase 1 trials are exploring the intravenous administration of two different MVA-based...

KØBENHAVN, Danmark, 16. december 2020 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Biomedical Advanced Research and Development Authority (BARDA), en del af Office of the Assistant Secretary...

COPENHAGEN, Denmark, December 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of...